Mcl-1 Inhibition: Managing Malignancy in Multiple Myeloma.
Al-Odat O, von Suskil M, Chitren R, Elbezanti W, Srivastava S, Budak-Alpddogan T, Jonnalagadda S, Aggarwal B, Pandey M.
Al-Odat O, et al.
Front Pharmacol. 2021 Jul 19;12:699629. doi: 10.3389/fphar.2021.699629. eCollection 2021.
Front Pharmacol. 2021.
PMID: 34349655
Free PMC article.
Review.